Cancer without disease.

Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med (2011) 5.54

A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature (2009) 3.44

Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer (2010) 3.27

Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol (2009) 2.20

Thrombospondins in cancer. Cell Mol Life Sci (2008) 2.08

Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev (2013) 1.91

Transcriptional network governing the angiogenic switch in human pancreatic cancer. Proc Natl Acad Sci U S A (2007) 1.85

Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis. Blood (2010) 1.81

The tumor microenvironment is a dominant force in multidrug resistance. Drug Resist Updat (2012) 1.77

Contribution of bone microenvironment to leukemogenesis and leukemia progression. Leukemia (2009) 1.77

Controversies in clinical cancer dormancy. Proc Natl Acad Sci U S A (2011) 1.71

NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels. J Clin Invest (2005) 1.65

Vascular endothelial growth factor: biology and therapeutic applications. Int J Biochem Cell Biol (2007) 1.55

Tailoring colorectal cancer screening by considering risk of advanced proximal neoplasia. Am J Med (2012) 1.54

Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors. Proc Natl Acad Sci U S A (2006) 1.54

Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors. Proc Natl Acad Sci U S A (2005) 1.51

Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue. Cancer Res (2010) 1.47

Cancer prevention by targeting angiogenesis. Nat Rev Clin Oncol (2012) 1.45

Cancer as robust intrinsic state of endogenous molecular-cellular network shaped by evolution. Med Hypotheses (2007) 1.39

Radiolabelled RGD peptides for imaging and therapy. Eur J Nucl Med Mol Imaging (2012) 1.33

Tumor stroma derived biomarkers in cancer. Cancer Metastasis Rev (2009) 1.32

Sustained expression of early growth response protein-1 blocks angiogenesis and tumor growth. Cancer Res (2006) 1.17

The biology and function of fibroblasts in cancer. Nat Rev Cancer (2016) 1.16

Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma. J Biol Chem (2011) 1.14

The role of stromal myofibroblast and extracellular matrix in tumor angiogenesis. Genes Cancer (2011) 1.14

Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer. Proc Natl Acad Sci U S A (2012) 1.12

K-Ras promotes angiogenesis mediated by immortalized human pancreatic epithelial cells through mitogen-activated protein kinase signaling pathways. Mol Cancer Res (2009) 1.06

Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts. BMC Cancer (2010) 1.05

Mutations in bone marrow-derived stromal stem cells unmask latent malignancy. Stem Cells Dev (2010) 1.05

Hypoxia in microscopic tumors. Cancer Lett (2008) 1.04

Leukocytes as paracrine regulators of metastasis and determinants of organ-specific colonization. Int J Cancer (2011) 1.04

Antiangiogenic gene therapy of cancer: recent developments. J Transl Med (2004) 1.03

In vivo quantitative microvasculature phenotype imaging of healthy and malignant tissues using a fiber-optic confocal laser microprobe. Transl Oncol (2008) 1.02

Downregulation of vascular endothelial growth factor and induction of tumor dormancy by 15-lipoxygenase-2 in prostate cancer. Int J Cancer (2009) 1.02

Non-stem cancer cell kinetics modulate solid tumor progression. Theor Biol Med Model (2011) 1.01

Consensus micro RNAs governing the switch of dormant tumors to the fast-growing angiogenic phenotype. PLoS One (2012) 0.99

Tamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypes. Breast Cancer Res (2009) 0.99

Angiogenesis in cancer: molecular mechanisms, clinical impact. Langenbecks Arch Surg (2007) 0.98

Gut microbiota and the paradox of cancer immunotherapy. Front Immunol (2014) 0.95

Drug resistance associated with antiangiogenesis therapy. Semin Cancer Biol (2009) 0.95

Inflamed tumor-associated adipose tissue is a depot for macrophages that stimulate tumor growth and angiogenesis. Angiogenesis (2012) 0.94

Inhibition of angiogenesis and HCT-116 xenograft tumor growth in mice by kallistatin. World J Gastroenterol (2007) 0.93

Tumor cell plasticity and angiogenesis in human melanomas. PLoS One (2012) 0.92

Tissue factor expression provokes escape from tumor dormancy and leads to genomic alterations. Proc Natl Acad Sci U S A (2014) 0.91

Preventive evolutionary medicine of cancers. Evol Appl (2012) 0.91

Prospective identification of glioblastoma cells generating dormant tumors. PLoS One (2012) 0.90

The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expression. Oncotarget (2016) 0.89

A VEGFR1 antagonistic peptide inhibits tumor growth and metastasis through VEGFR1-PI3K-AKT signaling pathway inhibition. Am J Cancer Res (2015) 0.89

Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancer. BMC Cancer (2009) 0.89

Metastatic mechanisms in follicular cell-derived thyroid cancer. Endocr Relat Cancer (2013) 0.88

Screening for cancer with molecular markers: progress comes with potential problems. Nat Rev Cancer (2012) 0.88

Transcriptional changes induced by the tumor dormancy-associated microRNA-190. Transcription (2013) 0.87

Pathogenic intestinal bacteria enhance prostate cancer development via systemic activation of immune cells in mice. PLoS One (2013) 0.86

Cancer Metastases: Early Dissemination and Late Recurrences. Cancer Growth Metastasis (2015) 0.86

Role of nutrition in preventing cancer. Can Fam Physician (2007) 0.86

Megakaryocytes, malignancy and bone marrow vascular niches. J Thromb Haemost (2012) 0.85

Peroxisome Proliferator-Activated Receptor-gamma Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer. PPAR Res (2008) 0.85

Cholera-toxin suppresses carcinogenesis in a mouse model of inflammation-driven sporadic colon cancer. Carcinogenesis (2014) 0.85

The microbiome modulates the tumor macroenvironment. Oncoimmunology (2014) 0.85

Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis. Ann Surg Treat Res (2015) 0.85

Integrins and their extracellular matrix ligands in lymphangiogenesis and lymph node metastasis. Int J Cell Biol (2012) 0.84

Novel Phenotypic Fluorescent Three-Dimensional Platforms for High-throughput Drug Screening and Personalized Chemotherapy. J Cancer (2013) 0.84

Applying ecological and evolutionary theory to cancer: a long and winding road. Evol Appl (2012) 0.84

Lovastatin inhibits VEGFR and AKT activation: synergistic cytotoxicity in combination with VEGFR inhibitors. PLoS One (2010) 0.84

A combinatorial approach for targeted delivery using small molecules and reversible masking to bypass nonspecific uptake in vivo. Gene Ther (2010) 0.83

Genotype analysis of the human endostatin variant p.D104N in benign and malignant adrenocortical tumors. Clinics (Sao Paulo) (2012) 0.82

Cellular localization, invasion, and turnover are differently influenced by healthy and tumor-derived extracellular matrix. Tissue Eng Part A (2014) 0.82

MMP9 processing of HSPB1 regulates tumor progression. PLoS One (2014) 0.82

Modeling progression in radiation-induced lung adenocarcinomas. Radiat Environ Biophys (2010) 0.82

Quantitative interpretation of a genetic model of carcinogenesis using computer simulations. PLoS One (2011) 0.82

Systems biology of tumor dormancy: linking biology and mathematics on multiple scales to improve cancer therapy. Cancer Res (2012) 0.82

Enhancing the anti-angiogenic action of histone deacetylase inhibitors. Mol Cancer (2007) 0.82

Angiogenin and vascular endothelial growth factor expression in lungs of lung cancer patients. Radiol Oncol (2012) 0.81

New concepts in breast cancer emerge from analyzing clinical data using numerical algorithms. Int J Environ Res Public Health (2009) 0.81

Global dormancy of metastases due to systemic inhibition of angiogenesis. PLoS One (2014) 0.81

Mechanisms of Cancer Cell Dormancy-Another Hallmark of Cancer? Cancer Res (2015) 0.81

Possible prognostic role of IL-17R in osteosarcoma. J Cancer Res Clin Oncol (2007) 0.81

Targeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: molecular basis for therapeutic implications. Cytokine Growth Factor Rev (2012) 0.81

Introduction to the tumour microenvironment review series. J Cell Mol Med (2009) 0.80

The anti-tumor properties of two tumstatin peptide fragments in human gastric carcinoma. Acta Pharmacol Sin (2009) 0.80

Protein Kinase D1 Signaling in Angiogenic Gene Expression and VEGF-Mediated Angiogenesis. Front Cell Dev Biol (2016) 0.80

Platelet proteome and tumor dormancy: can platelets content serve as predictive biomarkers for exit of tumors from dormancy? Cancers (Basel) (2010) 0.79

A review of Judah Folkman's remarkable achievements in biomedicine. Proc Natl Acad Sci U S A (2008) 0.79

Invasiveness and metastasis of retinoblastoma in an orthotopic zebrafish tumor model. Sci Rep (2015) 0.79

Low-Dose Mixture Hypothesis of Carcinogenesis Workshop: Scientific Underpinnings and Research Recommendations. Environ Health Perspect (2016) 0.78

The controversial clinicobiological role of breast cancer stem cells. J Oncol (2009) 0.78

Epithelial cancers in the post-genomic era: should we reconsider our lifestyle? Cancer Metastasis Rev (2013) 0.78

Insight On Colorectal Carcinoma Infiltration by Studying Perilesional Extracellular Matrix. Sci Rep (2016) 0.78

Novel Phenotypic Fluorescent Three-Dimensional Co-Culture Platforms for Recapitulating Tumor in vivo Progression and for Personalized Therapy. J Cancer (2013) 0.78

Emerging drug discovery approaches for selective targeting of "precursor" metastatic breast cancer cells: highlights and perspectives. Am J Transl Res (2011) 0.78

Targeting the vasculature of visceral tumors: novel insights and treatment perspectives. Langenbecks Arch Surg (2012) 0.78

High circulating VEGF level predicts poor overall survival in lung cancer. J Cancer Res Clin Oncol (2013) 0.78

Fluorescent cascade and direct assays for characterization of RAF signaling pathway inhibitors. Curr Chem Genomics (2008) 0.77

Clinical significance of serum and tumor tissue endostatin evaluation in operable non-small cell lung cancer. Biomed Rep (2014) 0.77

Breast and other cancer dormancy as a therapeutic endpoint: speculative recombinant T cell receptor ligand (RTL) adjuvant therapy worth considering? BMC Cancer (2010) 0.76

The interplay of extracellular matrix and microbiome in urothelial bladder cancer. Nat Rev Urol (2015) 0.76

Co-option of pre-existing vascular beds in adipose tissue controls tumor growth rates and angiogenesis. Oncotarget (2016) 0.76

Nanoparticle Based Combination Treatments for Targeting Multiple Hallmarks of Cancer. Int J Nano Stud Technol (2016) 0.75

Personalized Cancer Risk Assessments for Space Radiation Exposures. Front Oncol (2016) 0.75

Primary and metastatic tumor dormancy as a result of population heterogeneity. Biol Direct (2016) 0.75

The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol (2006) 11.16

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med (2007) 9.51

BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med (2003) 7.91

Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol (2008) 5.83

TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet (2005) 5.53

Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem (2007) 5.37

Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med (2010) 4.88

Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest (2004) 4.65

Origin and function of myofibroblasts in kidney fibrosis. Nat Med (2013) 4.55

Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther (2006) 4.20

Modification of kidney barrier function by the urokinase receptor. Nat Med (2007) 4.01

Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res (2007) 3.86

Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell (2003) 3.68

eRNAs are required for p53-dependent enhancer activity and gene transcription. Mol Cell (2012) 3.63

Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med (2010) 3.60

Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem (2003) 3.36

The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med (Berl) (2004) 3.32

Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. Cancer Cell (2012) 3.19

Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int (2002) 3.16

Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease. Proc Natl Acad Sci U S A (2006) 3.03

Endogenous inhibitors of angiogenesis. Cancer Res (2005) 2.88

Loss of β1-integrin from urothelium results in overactive bladder and incontinence in mice: a mechanosensory rather than structural phenotype. FASEB J (2013) 2.86

Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem (2007) 2.67

Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis. Nat Med (2013) 2.55

Biomolecular characterization and protein sequences of the Campanian hadrosaur B. canadensis. Science (2009) 2.48

Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis. Nat Med (2012) 2.44

Structure and function of basement membranes. Exp Biol Med (Maywood) (2007) 2.29

Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc Natl Acad Sci U S A (2003) 2.28

Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science (2002) 2.28

TGF-β1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis. J Am Soc Nephrol (2012) 2.24

Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc Natl Acad Sci U S A (2011) 2.21

Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol (2003) 2.20

The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol (2010) 2.18

Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors. Cancer Cell (2011) 2.17

Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem (2004) 2.13

Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl) (2013) 2.12

Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature (2008) 2.09

The role of the microenvironment in mammary gland development and cancer. Cold Spring Harb Perspect Biol (2010) 2.03

BMP-7 functions as a novel hormone to facilitate liver regeneration. FASEB J (2006) 2.02

Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology (2003) 1.97

Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors. Diabetes (2007) 1.94

Determinants of vascular permeability in the kidney glomerulus. J Biol Chem (2002) 1.93

Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem (2014) 1.92

Stem cell therapies benefit Alport syndrome. J Am Soc Nephrol (2009) 1.83

NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J Clin Invest (2002) 1.81

Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse. Am J Pathol (2007) 1.79

Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. J Biol Chem (2005) 1.79

Origins of cardiac fibroblasts. Circ Res (2010) 1.76

Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis. Am J Physiol Cell Physiol (2012) 1.70

Mice deficient in alpha-actinin-4 have severe glomerular disease. J Clin Invest (2003) 1.69

Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin. J Clin Invest (2005) 1.66

Transforming growth factor-β2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling. Biochem J (2011) 1.65

Mechanistic connection between inflammation and fibrosis. Kidney Int Suppl (2010) 1.64

Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells. Am J Pathol (2002) 1.63

VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. Proc Natl Acad Sci U S A (2011) 1.60

Integrin beta1-mediated matrix assembly and signaling are critical for the normal development and function of the kidney glomerulus. Dev Biol (2007) 1.60

Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J Biol Chem (2010) 1.58

Alpha-actinin-4 is required for normal podocyte adhesion. J Biol Chem (2006) 1.58

Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease. PLoS Med (2006) 1.54

Type IV collagen-derived angiogenesis inhibitors. Microvasc Res (2007) 1.51

Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors. Proc Natl Acad Sci U S A (2005) 1.51

Human antiglomerular basement membrane autoantibody disease in XenoMouse II. Kidney Int (2002) 1.50

Fibroblasts emerge via epithelial-mesenchymal transition in chronic kidney fibrosis. Front Biosci (2008) 1.44

Thrombospondin-1 associated with tumor microenvironment contributes to low-dose cyclophosphamide-mediated endothelial cell apoptosis and tumor growth suppression. Cancer Res (2004) 1.42

Tumor microenvironment and angiogenesis. Front Biosci (2008) 1.38

Epithelial-mesenchymal transition. Cancer Res (2008) 1.37

Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia. Nephrol Dial Transplant (2007) 1.37

Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype. Semin Cancer Biol (2012) 1.35

VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation. Cancer Res (2009) 1.32

Tumor stroma derived biomarkers in cancer. Cancer Metastasis Rev (2009) 1.32

Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy. Am J Pathol (2009) 1.29

Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment. Cancer Res (2003) 1.29

A role for nephrin, a renal protein, in vertebrate skeletal muscle cell fusion. Proc Natl Acad Sci U S A (2009) 1.26

Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy. Kidney Int (2004) 1.26

The importance of cell-mediated immunity in the course and severity of autoimmune anti-glomerular basement membrane disease in mice. FASEB J (2003) 1.25

Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. Kidney Int (2002) 1.24

Beta1 integrin expression on endothelial cells is required for angiogenesis but not for vasculogenesis. Dev Dyn (2008) 1.24

Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth. Biochem Biophys Res Commun (2005) 1.22

The VEGF pathway in cancer and disease: responses, resistance, and the path forward. Cold Spring Harb Perspect Med (2012) 1.21

Lymphocytes are dispensable for glomerulonephritis but required for renal interstitial fibrosis in matrix defect-induced Alport renal disease. Lab Invest (2008) 1.19

Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute. Circulation (2010) 1.18

Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice. Cancer Res (2006) 1.17

Cellular and molecular pathways that lead to progression and regression of renal fibrogenesis. Curr Mol Med (2005) 1.17

The biology of preeclampsia. Kidney Int (2009) 1.16

Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease. Kidney Int (2003) 1.15

Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma. J Biol Chem (2011) 1.14

The role of stromal myofibroblast and extracellular matrix in tumor angiogenesis. Genes Cancer (2011) 1.14

Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner. Proc Natl Acad Sci U S A (2011) 1.13

Animal models of renal fibrosis. Methods Mol Med (2005) 1.11

The role of type IV collagen and basement membranes in cancer progression and metastasis. Am J Pathol (2006) 1.11

Pre-eclampsia: connecting angiogenic and metabolic pathways. Trends Endocrinol Metab (2010) 1.10

Reversal of experimental renal fibrosis by BMP7 provides insights into novel therapeutic strategies for chronic kidney disease. Pediatr Nephrol (2008) 1.08

Experimental strategies to reverse chronic renal disease. Blood Purif (2004) 1.08

A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development. J Am Soc Nephrol (2002) 1.06

Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity. Proc Natl Acad Sci U S A (2008) 1.05

Basement membrane derived fibulin-1 and fibulin-5 function as angiogenesis inhibitors and suppress tumor growth. Exp Biol Med (Maywood) (2008) 1.04

The biology and function of exosomes in cancer. J Clin Invest (2016) 1.04

Transcriptional regulation of epithelial-mesenchymal transition. J Clin Invest (2007) 1.03

Preeclampsia: 2-methoxyestradiol induces cytotrophoblast invasion and vascular development specifically under hypoxic conditions. Am J Pathol (2010) 1.03

Interstitial fluid: the overlooked component of the tumor microenvironment? Fibrogenesis Tissue Repair (2010) 1.02